Abstract:Mammalian RAD52 is a DNA repair factor with strand annealing and recombination mediator activities that appear important in both interphase and mitotic cells. Nonetheless, RAD52 is dispensable for cell viability. To query RAD52 synthetic lethal relationships, we performed genome-wide CRISPR knock-out screens and identified hundreds of candidate synthetic lethal interactions. We then performed secondary screening and identified genes for which depletion causes reduced viability and elevated genome instability (increased 53BP1 nuclear foci) in RAD52-deficient cells. One such factor was ERCC6L, which marks DNA bridges during anaphase, and hence is important for genome stability in mitosis. Thus, we investigated the functional interrelationship between RAD52 and ERCC6L. We found that RAD52 deficiency increases ERCC6L-coated anaphase ultrafine bridges, and that ERCC6L depletion causes elevated RAD52 foci in prometaphase and interphase cells. These effects were enhanced with replication stress (i.e. hydroxyurea) and topoisomerase IIα inhibition (ICRF-193), where post-treatment effect timings were consistent with defects in addressing stress in mitosis. Altogether, we suggest that RAD52 and ERCC6L co-compensate to protect genome stability in mitosis. Mammalian RAD52 is a protein that protects DNA integrity through its roles in DNA repair and replication, and is being developed as a target for cancer treatment. To identify factors that influence dependence on RAD52 to maintain cell viability, we performed screens to identify genes that negatively impact cell viability and increase genome instability when disrupted in cells that also lack RAD52. Through these screens, we identified ERCC6L/PICH, a protein that helps resolve ultrafine DNA bridges, which can disrupt the segregation of sister chromatids during anaphase of mitosis. In characterizing the relationship between ERCC6L and RAD52, we found that RAD52 loss increases the number of DNA bridges marked by ERCC6L. Likewise, we discovered that ERCC6L depletion causes RAD52 to accumulate into foci in both mitosis and interphase. These effects were enhanced when loss of each protein was combined with agents that induce additional genotoxic stress (e.g., DNA replication stress). Our findings point to a model where RAD52 compensates for genotoxic stress caused by ERCC6L loss, and vice versa .

Rad52 Inactivation is Synthetically Lethal with BRCA2 Deficiency

RAD52 Adjusts Repair of Single-Strand Breaks via Reducing DNA-Damage-Promoted XRCC1/LIG3α Co-localization

Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells

RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis

53BP1 Loss Rescues Embryonic Lethality but Not Genomic Instability of BRCA1 Total Knockout Mice

BRCA2-DSS1 interaction is dispensable for RAD51 recruitment at replication-induced and meiotic DNA double strand breaks

Replication Protein A Phosphorylation Facilitates RAD52-Dependent Homologous Recombination in BRCA-Deficient Cells

RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers

The human RAD52 complex undergoes phase separation and facilitates bundling and end-to-end tethering of RAD51 presynaptic filaments

Nonhomologous End-Joining of Ionizing Radiation-Induced DNA Double-Stranded Breaks in Human Tumor Cells Deficient in BRCA1 or BRCA2.

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

Deficiency of Human BRCA2 Leads to Impaired Homologous Recombination but Maintains Normal Nonhomologous End Joining

RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability

RAD51 separation of function mutation disables replication fork maintenance but preserves DSB repair

BRCA2 Antagonizes Classical and Alternative Nonhomologous End-Joining to Prevent Gross Genomic Instability

Expression of BRC Repeats in Breast Cancer Cells Disrupts the BRCA2-Rad51 Complex and Leads to Radiation Hypersensitivity and Loss of G(2)/M Checkpoint Control.

53bp1 Inhibits Homologous Recombination In Brca1-Deficient Cells By Blocking Resection Of Dna Breaks

RAD52 Facilitates Mitotic DNA Synthesis Following Replication Stress.

Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand

Class I Histone Deacetylase Inhibition is Synthetic Lethal with BRCA1 Deficiency in Breast Cancer Cells

BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage